Compound 2115
Identifiers
- Canonical SMILES:
CNC(=N)c1cc2c(s1)c(cn(C)c2=O)-c1ccc(OC)c(OC)c1
- IUPAC name:
7-(3,4-dimethoxyphenyl)-N,5-dimethyl-4-oxo-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide
- InChi:
InChI=1S/C18H19N3O3S/c1-20-17(19)15-8-11-16(25-15)12(9-21(2)18(11)22)10-5-6-13(23-3)14(7-10)24-4/h5-9H,1-4H3,(H2,19,20)
- InChiKey:
OWJKWJIJOSMALG-UHFFFAOYSA-N
External links
![]() 127025419 |
![]() CHEMBL3770367 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 7.10 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 357.11 g/mol | |||
HBA | 6 | |||
HBD | 2 | |||
HBA + HBD | 8 | |||
AlogP | 1.91 | |||
TPSA | 76.39 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.5b00256 | compound 38 | BRD9 Q9H8M2 |
H4 P62805 |
Biochemical assay | Time-Resolved FRET BRD9 | pIC50 (half maximal inhibitory concentration, -log10) | 7.10 | |
10.1021/acs.jmedchem.5b00256 | compound 38 | BRD9 Q9H8M2 |
H4 P62805 |
Biochemical assay | Time-Resolved FRET BRD4(2) | pIC50 (half maximal inhibitory concentration, -log10) | 5.90 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4346 | Ilorasertib | DB11694 | |
0.4011 | Thieno[2,3-B]Pyridine-2-Carboxamidine | DB03876 | |
0.3992 | PF-04691502 | DB11974 | |
0.3968 | 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE | DB08788 | |
0.3964 | PF-00356231 | DB03367 | |
0.3936 | (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one | DB07430 | |
0.3900 | PRX-03140 | DB05596 | |
0.3900 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.3814 | Perampanel | DB08883 | |
0.3801 | 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one | DB07514 | |
0.3798 | CG-400549 | DB12347 | |
0.3750 | Brexpiprazole | DB09128 | |
0.3746 | Sufugolix | DB06494 | |
0.3732 | 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one | DB07528 | |
0.3694 | Relugolix | DB11853 |